Geniposide Protects against Obesity-Related Cardiac Injury through AMPKα- and Sirt1-Dependent Mechanisms

Our previous study found that geniposide, an agonist of glucagon-like peptide-1 receptor (GLP-1R), protected against cardiac hypertrophy via the activation of AMP-activated protein kinase α (AMPKα). However, the effects of geniposide on obesity-related cardiac injury remain unknown. Here, we examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhen-Guo, Kong, Chun-Yan, Song, Peng, Zhang, Xin, Yuan, Yu-Pei, Tang, Qi-Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247476/
https://www.ncbi.nlm.nih.gov/pubmed/30533173
http://dx.doi.org/10.1155/2018/6053727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247476/
https://www.ncbi.nlm.nih.gov/pubmed/30533173
http://dx.doi.org/10.1155/2018/6053727

Ejemplares similares